非梗阻性无精子症男性细针穿刺取精失败的风险预测模型
本研究基于597例非梗阻性无精子症(NOA)男性,用回顾性队列(317例)构建细针穿刺(FNA)取精失败的风险预测模型,纳入FSH水平、年龄和睾丸体积,模型AUC为82.3%(95%CI:77.6-87.1%),切点值64.61%,灵敏度0.677、特异度0.863;两个前瞻性外部验证队列(61例和219例)的预测准确率分别为85.25%和83.56%。作者建议对预测FNA失败风险高的NOA男性使用显微睾丸取精术(micro-TESE)。
要点
- 模型纳入FSH水平、年龄和睾丸体积预测NOA男性FNA取精失败风险。
- 模型AUC为82.3%(95%CI:77.6-87.1%),切点值64.61%,灵敏度0.677、特异度0.863。
- 两个外部验证队列预测准确率分别为85.25%和83.56%。
核心结论
- 包含FSH水平、年龄和睾丸体积变量的模型可以预测NOA男性FNA取精失败的风险。
- 作者建议对NOA且预测FNA失败风险高的男性使用显微睾丸取精术(micro-TESE)。
研究设计与样本
- 研究包含三个队列共597例NOA男性。
- 2015年1月1日至2017年7月31日,回顾性纳入317例在大学附属医院接受FNA的NOA男性,用于构建FNA取精失败风险预测模型。
- 2017年10月25日至2018年3月31日,前瞻性纳入来自同一医院和另一家生殖专科医院的61例和219例NOA男性两个队列,用于验证风险预测模型。
- 所有纳入男性均因生育治疗接受首次TESE手术。
主要发现
- 共327例(54.8%)NOA男性经历FNA取精失败。
- 预测模型纳入FSH水平、年龄和睾丸体积,AUC为82.3%(95%CI:77.6-87.1%)。
- 预测风险切点值为64.61%,灵敏度0.677,特异度0.863。
- 两个中心的外部验证集预测准确率分别为85.25%和83.56%。
- 两个中心分别有85.71%和85.15%经历取精失败的NOA患者被模型正确识别。
关键数值与推荐
- 模型预测FNA取精失败的AUC为82.3%(95%CI:77.6-87.1%),切点值64.61%,灵敏度0.677,特异度0.863。
- 外部验证队列预测准确率分别为85.25%和83.56%,取精失败正确识别率分别为85.71%和85.15%。
临床怎么用
- 作者建议对NOA且预测FNA失败风险高的男性使用显微睾丸取精术(micro-TESE)。
- 作者指出,对预测取精失败风险高的患者,可尝试取精率更高的TESA技术,而非终止产生遗传学后代努力。
局限性
- 小部分FNA成功取精的NOA男性被模型错误分类。
- 本研究未测试使用FNA获取的精子实现活产的能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can we predict the risk of sperm retrieval failure among men with non-obstructive azoospermia (NOA) before they undergo fine needle aspiration (FNA)? SUMMARY ANSWER: Our model, which includes FSH level, age and testicular volume as variables, can predict the risk of sperm retrieval failure with FNA. WHAT IS KNOWN ALREADY: Combined with ICSI, testicular sperm aspiration (TESA) can enable patients with NOA to have their own genetic offspring. Nearly all reproductive medicine centres in China have applied FNA, but approximately half of patients with NOA experience testicular sperm retrieval failure. Nevertheless, the models developed to predict the likelihood of obtaining spermatozoa with testicular sperm extraction (TESE) cannot accurately predict sperm retrieval, and few of these models have been sufficiently validated. STUDY DESIGN, SIZE, DURATION: This study involved three cohorts including 597 men with NOA. From 1 January 2015 to 31 July 2017, a retrospective cohort of 317 males with NOA who underwent FNA procedures at a university affiliated hospital were included to build a risk prediction model of sperm retrieval failure with FNA. Then, from 25 October 2017 to 31 March 2018, two prospective cohorts of 61 and 219 males with NOA from the same hospital and one other reproductive specialist hospital respectively, were recruited to validate the risk prediction model. PARTICIPANTS/MATERIALS, SETTING, METHODS: All men with NOA undergoing their first TESE procedure as part of a fertility treatment were included. The primary end-point was the presence of one or more spermatozoa (regardless of their motility) obtained with FNA. A binary multivariable logistic model was built to predict the risk of sperm retrieval failure after TESA using the dataset from the retrospective cohort. A cut-off value for risk was calculated with receiver operating characteristic (ROC) curve analysis. Two validation sets from the prospective cohort were used to validate the risk prediction model by measures including prediction accuracy and the true positive rate. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 327 (54.8%) males with NOA experienced sperm retrieval failure with FNA. FSH level, age and testicular volume were included in the prediction model for sperm retrieval failure risk. The model had an AUC of 82.3% (95% CI: 77.6-87.1%) and a cut-off value of 64.61% with a sensitivity of 0.677 and specificity of 0.863 for predicted risk. The predictive accuracies were 85.25 and 83.56% in the external validation sets from two centres. Specifically, 85.71 and 85.15% of NOA patients from two centres that experienced sperm retrieval failure were correctly identified using our model. LIMITATIONS, REASONS FOR CAUTION: A small proportion of males with NOA in whom sperm were successfully retrieved with FNA were misclassified; therefore, TESA techniques with higher sperm retrieval rates may be attempted in patients with high predicted risks of sperm retrieval failure rather than terminating the efforts to produce a genetic offspring. In addition, the ability to achieve a live birth using sperm retrieved with FNA was not tested in this study. WIDER IMPLICATIONS OF THE FINDINGS: We would recommend the use of micro-TESE for men with NOA and a high predicted risk of FNA failure. STUDY FUNDING/COMPETING INTEREST(S): This study was partly supported by National Key R&D Program of China (No. 2017YFC0907305), the National Natural Science Foundation of China (No.81803332), Sichuan Science & Technology Program (No. 2018SZ0144, 2016SZ0066, 2018SZ0284 and 2018FZ0043), Chengdu Science & Technology Bureau (No. 2018-YF05-01265-SN), Postdoctoral Research foundation of Sichuan University (No. 2018SCU12012) and West China Second University Hospital of Sichuan University (No. kx027). There are no competing interests related to this study. TRIAL REGISTRATION NUMBER: Not applicable.
引用
- Ma Y, Li F, Wang L, et al. A risk prediction model of sperm retrieval failure with fine needle aspiration in males with non-obstructive azoospermia. Hum Reprod. 2019. PMID: 30576444. doi:10.1093/humrep/dey366
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。